Vitamin D MS Prevention Trial
The Trish MS Research Foundation is helping
to fund a world-first clinical trial of vitamin D to test whether it may be
able to help prevent MS. Over the last decade the evidence that low levels of
vitamin D are associated with an increased risk of developing MS has been
However, if vitamin D supplementation is to be adopted as an early,
preventative intervention for people at high risk of developing MS, rigorous
evidence for optimum dosage, efficacy and safety is required from a carefully
designed randomised controlled trial.
Australian expertise in this area has made
Australia and New Zealand a pivotal location to conduct this trial. MS Research
Australia are coordinating the trial, with a consortium of highly experienced
MS neurologists, triallists, endocrinologists and epidemiologists.
20 sites in MS clinics around Australia and New Zealand
are continuing to enroll people who have experienced their first episode
suggestive of MS.
Participants will take a daily oral dose of one of three
doses of vitamin D or placebo for one year. The trial is progressing steadily
and results are expected in 2017.
For more information visit www.msra.org.au/prevanz